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Abstract To investigate metabolic changes during cellular
transformation, we used a 1H NMR based metabolite–
metabolite correlation analysis (MMCA) method, which
permits analysis of homeostatic mechanisms in cells at the
steady state, in an inducible cell transformation model.
Transcriptomic data were used to further explain the results.
Transformed cells showed many more metabolite–metabo-
lite correlations than control cells. Some had intuitively
plausible explanations: a shift from glycolysis to amino acid
oxidation after transformation was accompanied by a
strongly positive correlation between glucose and glutamine
and a strongly negative one between lactate and glutamate;
there were also many correlations between the branched
chain amino acids and the aromatic amino acids. Others
remain puzzling: after transformation strong positive cor-
relations developed between choline and a group of five
amino acids, whereas the same amino acids showed negative
correlations with phosphocholine, a membrane phospholipid
precursor. MMCA in conjunction with transcriptome anal-
ysis has opened a new window into the metabolome.
Keywords Metabolomics  Cellular transformation 
NMR  Metabolite correlations
1 Introduction
There is currently much interest in studying the metabo-
lome, the totality of small-molecule metabolites through
which genes and enzymes create and control the cellular
metabolic phenotype. However, the complex and rapid
interactions between metabolites make the metabolome
much harder to understand than the genome or proteome.
Even if it were currently possible to specify the instanta-
neous concentrations of the several thousand metabolites in
a cell, one would also need to understand the myriad
interactions between them in order to have a useful picture
of the metabolome. Current methods such as metabolic
tracer studies can only tackle small subsets of the problem.
Metabolite–metabolite correlation analysis (MMCA)
(Fiehn and Weckwerth 2003; Kose et al. 2001; Steuer
2006; Steuer et al. 2003a, b) offers a radically new insight
into the metabolome. It is based on the observation that
when many apparently identical samples (e.g. aliquots of
cultured cells) are analysed, the ‘‘biological variation’’ in
the metabolite concentrations will reflect the tiny home-
ostatic adjustments that maintain the metabolome in a
steady state. Thus, the concentrations of certain metabo-
lites will be correlated, either positively if a rise in the
concentration of one metabolite is associated with a rise
in the concentration of a second metabolite, or negatively
Electronic supplementary material The online version of this
article (doi:10.1007/s11306-015-0838-z) contains supplementary
material, which is available to authorized users.
IMR90 cells were purchased from ATCC as we stated in ‘‘Materials
and methods’’ section. IMR-90 (ATCC CCL-186).
This article is dedicated to the memory of Dr. Marion Stubbs (19th
Jan 1942–8th Sept 2012).
& Basetti Madhu
Madhu.Basetti@cruk.cam.ac.uk
1 Li Ka Shing Centre, Cancer Research UK Cambridge
Institute, University of Cambridge, Robinson Way,
Cambridge CB2 0RE, UK
2 Department of Medical Epidemiology and Biostatistics,
Karolinska Institutet, Stockholm, Sweden
3 Early Clinical Biometrics, AstraZeneca AB R&D, Mo¨lndal,
Sweden
123
Metabolomics (2015) 11:1848–1863
DOI 10.1007/s11306-015-0838-z
if a rise in the concentration of the first metabolite is
associated with a fall in the concentration of a second
metabolite. The demonstration of such correlations in
unperturbed, apparently identical biological systems has
opened a new window on metabolic research, allowing
monitoring of the effects of cellular perturbations on
signalling mechanisms and/or metabolic pathways, even if
no detectable changes in mean metabolite concentrations
are observed (Hannah et al. 2010; Urbanczyk-Wochniak
et al. 2007). Sometimes the mechanism underlying the
MMCA change is intuitively obvious, as when several
adjacent compounds in a metabolic pathway are positively
correlated, although correlations between adjacent com-
pounds in a pathway are not, in fact, always observed
(Camacho et al. 2005). However, correlations, particularly
negative correlations, are also frequently seen between
apparently unrelated compounds in widely separated
pathways, suggesting the existence of hitherto unknown
metabolic control mechanisms or other interactions. The
MMCA method was introduced in the field of plant sci-
ence (Fiehn and Weckwerth 2003; Kose et al. 2001;
Steuer et al. 2003a, b) and it has subsequently been used
for analysis of data obtained from body fluids (Dunn et al.
2015; Lanza et al. 2010). A recent study investigated
correlation analysis of gas chromatography–mass spec-
trometry (GC–MS) metabolite data from two cancer cell
lines cultures under normoxic and hypoxic conditions
(Kotze et al. 2013). To our knowledge, ours is the first
paper to report the use of NMR based MMCA data on
cultured mammalian cells.
At present it is not possible to measure the complete
metabolome. Subsets of the metabolome, often referred to
as ‘‘metabolic profiles’’, can be obtained by mass spec-
trometry or 1H NMR spectroscopy. NMR, although much
less sensitive than mass spectrometry, gives metabolic
profiles in which the relative metabolite concentrations
are known very precisely, which is ideal for MMCA. We
therefore used it to study malignant transformation, the
process whereby cells gain the properties of cancer by
activation of oncogenes and inactivation of tumour sup-
pressor genes (Weinberg 1994, 1995), a problem that has
been intensively studied at the levels of the genome,
transcriptome and proteome (Deng et al. 2005; Mason
et al. 2006; Vasseur et al., 2003, 2005, ; Woo and Poon
2004; Zongaro et al. 2005). We studied a well-established
in vitro transformation system in human diploid fibrob-
lasts (HDFs) using an implementation of the MMCA
methodology that we have developed (Jauhiainen et al.
2014). Finally, we integrated gene expression and meta-
bolic data (both quantitative and correlative) in a detailed
study of the branched chain amino acid catabolic
pathway.
2 Materials and methods
2.1 Vectors and antibodies
Ectopic genes were introduced to cells by retrovirus-me-
diated gene transfer (Young et al. 2009) using the retroviral
vectors pLNCX2-Neo (ER:H-RASG12V) and pWZL-Hygro
(E1A). Immunoblotting (Young et al. 2009) utilized the
following antibodies: anti-H-RAS, anti-E1A and anti-
HMGA2 (Santa Cruz); anti-ß-actin, anti-cyclin A2, and
anti-p53 (Sigma); anti-PARP (Cell Signaling).
2.2 Cell culture
To compare metabolites between normal and transformed
cells from the same cell line with minimal genetic pertur-
bations, we utilized IMR90 cells, a well-established
genetically normal human diploid fibroblast (HDF) cell
model that can be transformed by ectopic expression of
certain combinations of oncogenes. For example, aden-
oviral oncoprotein E1A, which when used alone can
immortalize HDFs, cooperates with oncogenic RAS to
transform them, at least in vitro (Narita et al. 2006; Serrano
et al. 1997).
IMR90 cells (ATCC) were cultured in DMEM supple-
mented with 10 % FBS. We have previously described the
utility of a 4-hydroxytamoxifen (4-OHT) inducible form of
oncogenic H-RASG12V that is fused to the hormone binding
domain of the human estrogen receptor (ER::RAS) (Young
et al. 2009). To generate E1A/RAS transformed HDFs for
MMCA, we first stably expressed ER::RAS in IMR90
cells. A pool of the ER::RAS expressing cells was next
super-infected with the E1A expressing retrovirus. After a
brief selection for E1A expressing cells, ER::RAS was
induced by 100 nM 4-OHT. To minimize additional
mutations, cells were utilized as soon as possible after
antibiotic selection and ER::RAS induction.
For control HDF cells (Narita et al. 2006; Serrano et al.
1997), 7 biological replicates were grown, and 10 batches
extracted from them, with n = 5, 5, 4, 6, 5, 3, 5, 6, 4, and 9
samples, comprising in total 52 samples. For E1A/RAS, 7
biological replicates were created, with n = 6, 6, 6, 8, 8,
12, and 7 samples, giving in total 53 samples. Each cohort
was grown to a population of 106 cells before harvesting
with perchloric acid, which extracted their water-soluble
metabolites.
2.3 Sample preparation and 1H NMR analysis
Water-soluble metabolites were extracted with perchloric
acid from samples of approximately 106 cells (Madhu
et al. 2006), neutralized, lyophilized and re-suspended in
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1 ml of D2O; 600 ll of the sample was placed in a 5 mm
Wilmad standard NMR tube and 10 ll of 10 mM TSP
was added as the chemical shift and quantitation standard.
1H NMR spectra were acquired with a 5 mm inverse
broadband probe (BBI) equipped with an automated tun-
ing and matching device (ATM), on a Bruker Avance
600 MHz NMR spectrometer (with a TOPSPIN 2.3 soft-
ware). Data was acquired with a water pre-saturation
pulse sequence with 128 averages, 5 s repetition time and
64 K time domain data points. All free induction decays
(FIDs) were pre-processed by 0.3 Hz line broadening,
Fourier transformation, zero and first order phase cor-
rection. Chemical shifts for metabolites were assigned
from our own 2D-NMR spectral (COSY and TOCSY)
data and also cross checked from the human metabolomic
data base (HMDB; http://www.hmdb.ca/)). Absolute
quantitation of TSP was estimated using the ERETIC2
(Electronic Reference To access In vivo Concentrations)
module in Bruker Topspin 3.0, which is based on the
PULCON principle (PUlse Length based CONcentrations
determination) (Akoka et al. 1999; Dreier and Wider
2006; Esmaeili et al. 2014; Wider and Dreier 2006).
Metabolites were identified following the Metabolomics
Standards Initiative (MSI) guidelines (Sansone et al.
2007) and the metabolite identifiers from ChEBI (http://
www.ebi.ac.uk/chebi) to the observed metabolites are
presented in supplementary Table 1s. Intracellular
metabolite concentrations were estimated using the NMR
suite 7.5 (Chenomx Software package) and then nor-
malized to the protein content in the cell sample. Media
metabolite concentrations (lmoles) were normalized to
cell numbers and incubation time.
2.4 Metabolite–metabolite correlation coefficients
The metabolite concentrations within each group were
normalized using a mixed model approach. For control
HDF samples, a mixed model with fixed metabolite effects,
as well as random effects for cohorts, batches and samples
was adapted. For E1A/RAS samples, a similar mixed
model was adapted, but including only random effects for
the cohorts and samples, as no batches were present. A
covariance matrix between the metabolites in each treat-
ment group was estimated simultaneously with the
parameters in the mixed model. To correct for multiple
testing, the false discovery rate (the expected proportion of
false discoveries among the rejected hypotheses) was
controlled using the Benjamini-Hochberg method when
testing the Pearson correlations. All statistical analysis was
performed using the open source statistical software R,
with the hglm package (available from the CRAN reposi-
tory) (Jauhiainen et al. 2014).
2.5 Minimum sample size
The MMCA studies reported herein were performed on
datasets of [50 identical samples. What would be the
minimum practical number of samples for such a study?
For practical purposes we are only concerned with mea-
suring the strong or medium correlations since we elimi-
nate results from the weakly correlated pairs. Another
simplification can be made because for cultured cell or
tissue extract samples the number of metabolites measur-
able by 1H NMR method will usually be similar to that
observed in the present study.
We illustrate the effect of sample size by using our data
obtained from the control cell lines. In total we have 52
samples with measures of 28 metabolites. A subset of
correlations was selected randomly from three categories:
high, medium and no correlation. We have glycine-choline
(correlation around -0.7, labelled as high on an absolute
scale), aspartate-glutamate: (correlation around 0.5, label-
led as medium), and leucine–lactate (no correlation).
Parametric bootstrap is used to illustrate the behaviour
for decreasing sample sizes. From the observed correla-
tions and mean values of metabolite levels in the normal-
ized data, 10,000 datasets are simulated, each with 52
samples and 28 metabolites, under the normal distribution
(which fits the data well). The metabolite–metabolite cor-
relations are calculated for each simulated dataset, using
from 5 up to all 52 samples. A typical (median) sequence
of correlations (under different sample sizes) is chosen
from the simulated sets for each of the three metabolite–
metabolite correlations and plotted with confidence inter-
vals in Supplementary Fig. S1. 10 randomly selected
sequences of correlations are also shown for each corre-
lation pair to illustrate that the correlation estimates
become highly variable for smaller sample sizes.
Power calculations for correlations can also be of use in
sizing an MMCA study. In order to achieve 80 % power
for a single test, 30 samples would be required for a cor-
relation of 0.5, and 14 samples for a correlation of 0.7 (with
a two-sided 0.05 level test under a normal distribution
assumption). When correcting for multiplicity, the correc-
tions depend on the number of tests, and for FDR correc-
tion, on the dependence structure between tests (which
generally is unknown before the study is performed). Based
on our data from the control cell lines, simulation shows
that adding 8-10 additional samples is needed for correla-
tion 0.5 and 6 samples for correlation 0.7 in order to control
the FDR at the 0.05 level.
2.6 Gene expression data acquisition and analysis
Total RNA was extracted from five independent biological
replicates of control or E1A/RAS expressing IMR90 cells.
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Gene expression analysis was carried out on Illumina
Human HT12 version 3 arrays. All data analyses used the
software R and packages from the Bioconductor project
(Gentleman et al. 2004). Raw intensity data from the array
scanner was processed using the BASH (Cairns et al. 2008)
and HULK algorithms as implemented in the beadarray
package (Dunning et al. 2007). Log2 transformation and
quantile normalisation of the data were performed across
all sample groups. Differential expression analysis used the
LIMMA package (Smyth 2005) from the Bioconductor
project. Differentially expressed genes were selected using
the significance level P\ 0.05 as the cut-off after appli-
cation of FDR correction for multiple testing. The Reac-
tome pathway software was used to visualize the gene
expression variations along the metabolic pathways.
Unless otherwise stated, all results refer to E1A/RAS
cells compared to control HDF cells.
3 Results
3.1 Cell culture
E1A/RAS-transformed cells showed a typical ‘E1A-mor-
phology’, a relatively uniform polygonal shape compared
to control HDF cells (Fig. 1a). We also confirmed in three
independent E1A transductions the typical protein expres-
sion pattern of E1A/RAS-transformation: stabilization of
p53 and upregulation of cyclin A2 (a biochemical marker
of cell cycle progression) and p16 (a positive upstream
regulator of the RB family, which is blocked by E1A). E1A
also sensitizes cells to apoptosis, largely depending on p53,
and we consistently observed modest basal levels of
cleaved PARP, a marker of apoptosis (Fig. 1b).
3.2 Metabolite uptake and output
We analysed the culture media every three days by 1H
NMR spectroscopy. Metabolite uptake or secretion by
control HDFs was found to be similar (as expected) in
media from 0–3 to 3–6 days of cell culture; in contrast,
metabolite concentrations changed throughout the 12 days
during E1A/RAS transformation. Control HDF media
results from 0–3 to 3–6 days are therefore compared with
transformed cell media results at 0–3, 3–6, 6–9 and
9–12 days. Glucose consumption and lactate secretion
were significantly higher in E1A/RAS cells compared to
control cells from day 3 until day 12 after RAS-induction
(Fig. 2a), suggesting that transformation causes the devel-
opment of a more glycolytic phenotype. Consumption of
glutamine (gln), another major substrate of E1A/RAS-
transformed cells (DeBerardinis et al. 2007), was signifi-
cantly higher from day 3 onwards in transformed cells
(Fig. 2b); there was also a significant increase in glutamate
(glu) secretion (Fig. 2b) from day 3 onwards. Figure 2b
also shows secretion of pyro-glu, citrate, fumarate and
PARP
p53
Cyclin A2
Act
Ras
p16
E1A
G E1a
Ras
#1  
G E1aRas
#3  
G E1aRas
#2  IMR90 Growing 
IMR90 E1a/Ras 
Control 
C C C
E1A/RAS
a bFig. 1 a Phase contrast images
of control and E1A/RAS
transformed cells. b Protein
expression data from western
blots. E1A/RAS expressing
cells show marked differences
in expression of RAS, E1A and
P16 compared to control HDF
cells (c)
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acetate. Supplementary Figure S2 summarises concentra-
tion changes of the amino acid that could be quantified in
the media of transformed cells: there was consumption of
isoleucine (ile), leucine (leu), valine (val), lysine (lys), and
tyrosine (tyr) and secretion of glycine (gly) and formate,
along with modulation of phenylalanine (phe) and
methionine (met) levels.
3.3 Intracellular metabolites
Representative 1H NMR spectra of perchloric acid extracts
of control and E1A/RAS cells at day 12 are shown in
Fig. 3. It was necessary to analyse more than 50 samples in
each group in order to perform MMCA, so we obtained
good statistical significance in our metabolite concentration
results. Intracellular glucose was significantly lower in
E1A/RAS cells but there was no significant difference in
lactate; alanine (ala) was significantly higher and pyruvate,
gln and glu were significantly lower (Fig. 4a).
E1A/RAS cells showed no change in intracellular
phosphocholine (PC), but significant increases in choline
(Cho) and phosphoethanolamine (PE) and a significant
decrease in glycerophosphocholine (GPC) were observed
while betaine (a Cho breakdown product) was also sig-
nificantly lower (Fig. 4a).
Intracellular Cr, PCr and NAD? were significantly
higher in E1A/RAS cells whereas ATP was significantly
lower (Fig. 4a) and the ratio of PCr/Cr was significantly
higher (Supplementary Fig. S3). Because the creatine
kinase reaction is close to equilibrium, the PCr/Cr can be
used as a surrogate for ATP/ADP; this result therefore
suggests that the transformed cells were in a higher ener-
getic state.
We found that 12 amino acids (glu, gln, gly, ile, leu, lys,
met, phe, ser, threonine (thr), tyr and val) had significantly
lower intracellular levels in transformed cells; only ala was
increased and only aspartate (asp) was unchanged (Fig. 4a,
b). Note that arginine, asparagine, cysteine, histidine, and
proline could not be quantified because their concentrations
were too low.
Interestingly, fumarate, a tricarboxylic acid (TCA) cycle
metabolite that is considered to be an ‘oncometabolite’
when it accumulates because of genetic deficiency of
fumarate hydratase, was increased more than twofold in
transformed cells (Fig. 3b). However, there was no sig-
nificant difference between the HIF-1A expressions of the
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Fig. 2 a Metabolites associated with the glycolytic pathway were
measured in culture medium from control and E1A/RAS transformed
cells. The P values (from Student’s t test) for days 0–3 and days 3–6
show the significance when comparing E1A/RAS transformed and
control HDF cells media samples on the corresponding days.
b Metabolites associated with the gln pathway were measured in
culture medium from control and E1A/RAS transformed cells. The P-
values (from Student’s t test) for days 0–3 and days 3–6 show the
significance when comparing E1A/RAS transformed and control HDF
cells media samples on the corresponding days
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transformed cells compared to controls when cultured
under normoxic conditions, suggesting that transformation
did not cause pseudohypoxic HIF-1 activation (data not
shown).
The taurine concentration was significantly higher in
transformed cells but there were no changes in the intra-
cellular concentrations of asp, citrate, myo-inositol or
glutathione (Fig. 3b). A diagrammatic summary of all the
intra- and extracellular metabolic modifications observed
in E1A-Ras transformed cells compared to control HDFs is
shown in Fig. 5.
3.4 Metabolite–metabolite correlation analysis
MMCA heat maps (Fig. 6) were constructed from the
intracellular metabolite data obtained from large numbers
of identical cultures of control HDF cells (n = 52) and
E1A/RAS cells (n = 53). Out of 378 pair-wise correla-
tions from 28 metabolites, 23 positive (yellow to red) and
26 negative (shades of blue) correlations (together about
13 % of the total) were observed in controls; in contrast
72 positive and 90 negative correlations (together about
43 % of the total) were observed in transformed HDFs.
This more than threefold increase in metabolite–metabo-
lite correlations (both positive and negative) reflects the
adjustments in the metabolic pathways as the cells
underwent transformation. Since metabolism is often
described in terms of hierarchical and modular networks
(Ravasz et al. 2002), we next classified the metabolite–
metabolite correlations according to the main metabolic
pathways.
The correlations were divided into six biochemical
modules: glycolysis (glucose, lactate, ala and pyruvate),
energy metabolism (Cr, PCr, NAD? and ATP), membrane
metabolism (Cho, PC, PE, myo-inositol and GPC), gln and
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Fig. 2 continued
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glu metabolism, TCA cycle (asp, citrate and fumarate) and
amino acid metabolism (gly, taurine, thr, ser, ile, leu, val,
phe, tyr, and lys) (Fig. 6).
In the glycolysis module, negative correlations were
found between glucose and ala both in the control and
transformed cells. Two correlations in the controls, positive
12
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Control
Control
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Fig. 3 1H NMR spectra of
metabolite extracts from control
(lower) and E1A/RAS treated
HDFs (upper). 1 Branched chain
amino-acids (leucine,
isoleucine, valine), 2 Ethanol, 3
Lactate, 4 Alanine, 5 Acetate, 6
Glutamate, 7 Glutamine, 8
Succinate, 9 Aspartate, 10
Creatine and Phosphocreatine,
11 Choline containing
compounds (Choline, PC and
GPC), 12 Beta-glucose, 13
Methanol, 14 Glycine, 15
Glucose signals, 16
Myoinositol, 17 Alpha-glucose,
18 Fumarate, 19 Tyrosine, 20
Phenylalanine, 21 Formate
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between glucose and pyruvate, and negative between ala
and pyruvate, were lost on transformation, but a new
positive correlation between lactate and ala was observed.
In the energy metabolism module, there were no correla-
tions between any metabolites in the controls whereas two
new correlations, positive between Cr and ATP and nega-
tive between Cr and PCr, were observed after
transformation.
In the membrane metabolism module, a positive corre-
lation observed between Cho and GPC in control HDFs
was not maintained in the transformed samples. Instead,
three new, strong negative correlations, one between Cho
and PC, a second between Cho and myo-inositol and a third
between Cho and PE, were observed. There was also a
strong positive correlation between myo-inositol and PC
after transformation.
The TCA cycle module showed no correlations in con-
trol HDFs but a new positive correlation between asp and
citrate was observed in the transformed cells. In the amino
acid metabolism module, a positive correlation between
gly and thr was preserved in both control and transformed
samples and a new, strong positive correlation between gly
and taurine was observed in the transformed samples.
Transformation induced strong correlations between
Control E1A/Ras
0
200
400
600
800
1000
Glucose
m
ic
ro
m
ol
es
/ m
g 
pr
ot
ei
n 
co
nt
en
t
m
ic
ro
m
ol
es
/ m
g 
pr
ot
ei
n 
co
nt
en
t
m
ic
ro
m
ol
es
/ m
g 
pr
ot
ei
n 
co
nt
en
t
m
ic
ro
m
ol
es
/ m
g 
pr
ot
ei
n 
co
nt
en
t
m
ic
ro
m
ol
es
/ m
g 
pr
ot
ei
n 
co
nt
en
t
m
ic
ro
m
ol
es
/ m
g 
pr
ot
ei
n 
co
nt
en
t
m
ic
ro
m
ol
es
/ m
g 
pr
ot
ei
n 
co
nt
en
t
m
ic
ro
m
ol
es
/ m
g 
pr
ot
ei
n 
co
nt
en
t
m
ic
ro
m
ol
es
/ m
g 
pr
ot
ei
n 
co
nt
en
t
m
ic
ro
m
ol
es
/ m
g 
pr
ot
ei
n 
co
nt
en
t
m
ic
ro
m
ol
es
/ m
g 
pr
ot
ei
n 
co
nt
en
t
m
ic
ro
m
ol
es
/ m
g 
pr
ot
ei
n 
co
nt
en
t
m
ic
ro
m
ol
es
/ m
g 
pr
ot
ei
n 
co
nt
en
t
m
ic
ro
m
ol
es
/ m
g 
pr
ot
ei
n 
co
nt
en
t
m
ic
ro
m
ol
es
/ m
g 
pr
ot
ei
n 
co
nt
en
t
m
ic
ro
m
ol
es
/ m
g 
pr
ot
ei
n 
co
nt
en
t
Control E1A/Ras
0
100
200
300
400
Lactate
Control E1A/Ras
0
50
100
150
Alanine
Control E1A/Ras
0
5
10
15
20
Pyruvate
Control E1A/Ras
0
100
200
300
400
Glutamine
Control E1A/Ras
0
200
400
600
Glutamate
Control E1A/Ras
0
1
2
3
4
Choline
Control E1A/Ras
0
10
20
30
40
Phosphocholine
Control E1A/Ras
0
10
20
30
40
Glycero-Phosphocholine
Control E1A/Ras
0
10
20
30
40
50
Phosphoethanolamine
Control E1A/Ras
0
10
20
30
40
Creatine
Control E1A/Ras
0
20
40
60
80
Phosphocreatine
Control E1A/Ras
0
10
20
30
40
50
ATP
Control E1A/Ras
0
5
10
15
20
NAD+
Control E1A/Ras
0
1
2
3
4
5
Creatinine
Control E1A/Ras
0
1
2
3
Betaine
**** p<0.0001  ** p<0.001  * p<0.01
a
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choline metabolites and some amino acids: Cho showed
positive correlations with ile, leu, val, phe, tyrosine and lys,
whereas PC showed negative correlations with all these
amino acids; interestingly ATP and myo-inositol had
almost identical amino acid correlation patterns to PC.
A positive correlation between ile and val in controls
was preserved after transformation, in addition to a set
of new, strong positive correlations that appeared
between the amino acids ile, leu, val, phe, tyr and lys.
Ile and ser both showed strong negative correlations
with gly, taurine and thr. No correlation between gln
and glu was observed in either control or transformed
cells. Gln and ala showed no correlations with any of
the other amino acids, apart from a negative one
between ala and lys in the control HDFs. Glu showed
no interactions with other amino acids in the control
HDFs, but in the transformed cells it showed strong
negative correlations with all the amino acids apart
from ser, thr and ala.
The branched chain amino acids, ile, leu and val, which
are often lumped together, since they are used as oxidative
substrates by several organs, showed no correlations in the
control HDFs but had intense positive correlations in the
transformed cells (Fig. 6).
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3.5 Gene expression
Several glycolytic pathway genes are significantly up-reg-
ulated in transformed cells (Supplementary Fig. S7)
including genes for glucose transporters (SLC2A4 and
SLC2A5) and glycolytic enzymes (PFKM (phosphofruc-
tokinase, muscle), ALDOA/B/C (fructose-bisphosphate
aldolase A, B, and C), GAPDH/S (glyceraldehyde-3-
phosphate dehydrogenase, testis-specific), PGK1 (phos-
phoglycerate kinase 1), PGAM1/2/4/5 (phosphoglycerate
Lactate 
Glutamine 
Glucose 
Glutamate 
GPC  
Glucose 
Glutamine 
Glutamate
Amino
Acids  
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Lactate 
Pyruvate 
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-KG
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Fig. 5 Metabolite
concentration changes
comparing control to E1A/RAS
transformed cells (Red—
increased, blue—decreased,
black—no change). Measured
intra-cellular metabolites are
shown with broken line boxes.
PCr phosphocreatine; Cr
creatine (Color figure online)
Fig. 6 Metabolite–metabolite correlation heat maps of control and E1A/RAS induced transformed HDF cells. Correlations shown are those that
correspond to an FDR-corrected P-value\0.001
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mutase 1, 2, 4, and 5), ENO2 (enolase 2), PKLR (pyruvate
kinase, liver and red blood cell), LDHA and LDHB (lactate
dehydrogenase A and B).
Supplementary Figures S8 and S9 show expression of
branched chain amino acid catabolism genes. In E1A/RAS
HDFs branched chain amino acid transferase1 (BCAT1)
(cytosolic) expression is lowered, whereas BCAT2 (mito-
chondrial) expression is up regulated, suggesting amino
acid transfer into the mitochondria for catabolism. Signif-
icantly upregulated expression of the branched-chain alpha
ketoacid dehydrogenase complex, 3-methylcrotonyl-CoA
carboxylase, 3-hydroxyacyl-CoA dehydrogenase, acetyl-
CoA acetyltransferase (mitochondrial) and 3-hydroxy-
isobutyrate dehydrogenase was observed (Supplementary
Fig. S9).
Supplementary Figure S10 shows expression fold
changes for proteins in the phe-tyr catabolic pathway that
were significantly differentially expressed after transfor-
mation: expression of cysteine conjugate-beta lyase and
fumaryl acetoacetase was down-regulated whereas pterin-4
alpha-carbinolamine dehydratase and maleylacetoacetate
isomerase expression was elevated. Concentrations of
fumarate and acetate, the end-products of the phe-tyr
catabolic pathway, were significantly higher in E1A/RAS
cells.
Correlations between the TCA cycle, amino acid meta-
bolism and glycolysis genes that were significantly differ-
entially expressed upon transformation are presented in
Supplementary Fig. S11. It is evident from this figure that
due to the E1A/RAS transformation, PSAT1 gene expres-
sion retained its positive correlation with PHGDH, ASNS
and BCKDHA (all these are in amino acid pathway), but
lost positive correlation with PCR1, FH (TCA cycle) and
PFKB3 (glycolysis). Another amino acid pathway gene,
BCKDHA, retained its positive correlation with ASNS,
PHGDH, PSAT1 (all from amino acid pathway) but lost its
positive correlation with PYCR1 (TCA cycle) and GP1
(glycolysis) after E1A/RAS transformation. In addition
BCKDHA gene expression showed new positive correla-
tions with SUCLG1 and IDH3B (both from the TCA
cycle), PCBD1, BCAT2 and GPT2 (all from amino acid
pathways) and ALDOC (glycolysis). Surprisingly, FH, a
TCA cycle gene that has oncogenic effects when mutated
(Tomlinson et al. 2002), retained its negative correlation
with PHGDH and ASNS (both from amino acid pathways)
and lost its negative correlation with PSAT1 (amino acid
pathway) and PYCR1 (TCA cycle) after E1A/RAS trans-
formation. In addition, after E1A/RAS transformation FH
gene expression established new negative correlations with
expression of the BCKDHA (amino acid pathway),
ALDOC (glycolysis) and SUCLG1, IDH3B and ACAT1
(TCA cycle) genes.
4 Discussion
Classical metabolic studies mainly utilise measurements of
metabolite concentrations and fluxes through specific meta-
bolic reactions or pathways, supplemented in recent years
with gene expression data. Previous studies on transformation
of cell lines thus focused on genetic events (Mason et al.
2006), glycolysis (Telang et al. 2006) or alterations in the
glycolytic and glutaminolytic pathways (Mazurek et al. 1999)
and in oxidative phosphorylation (de Groof et al. 2009).
Metabolomic studies require a broader, more statistically
based approach, utilising methods such as PCA and OPLS-
DA. However, these latter methods do not indicate specific
interactions between metabolites. In the present study,
therefore, as well as measuring metabolite concentrations,
substrate utilisation and gene expression, and using metabo-
lomic methods such as PCA and OPLS-DA, we have intro-
duced an MMCA method with a new normalization strategy
which efficiently corrects for batch and cohort effects
(Jauhiainen et al. 2014). The MMCA method is different from
the STOCSY (Cloarec et al. 2005) analysis method, as we
have de-convoluted the individual metabolite signals; abso-
lute metabolite concentrations were obtained and then used
for estimating the correlations. Our biochemical modular
method of plotting the pairwise metabolite correlations
(Fig. 6) provides an easy insight into the cellular metabolism
along established biochemical pathways.
Conventional PCA analysis (Supplementary Fig. S4)
demonstrated that the most important metabolite concen-
trations that differentiated transformed cells from control
cells were glucose, glut, gln, lactate, acetate and formate.
An OPLS DA analysis showed that the metabolite con-
centrations that best distinguished the control from the
transformed cells were glucose, amino acids, Cr, PCr and
PC (Supplementary Figs. S5 and S6). Neither method
offered any insights into the interrelationships between the
metabolites. By using MMCA we were able to make a
more sophisticated analysis.
There were many more metabolite–metabolite correla-
tions in the E1A/RAS transformed cells (72 positive and 90
negative) than the control cells (23 positive and 26 nega-
tive), suggesting that transformed cells activate additional
metabolic control mechanisms to bring about the pheno-
typic changes characteristic of transformation (Fig. 6). We
have previously found that any genetic or environmental
perturbation tends to increase the number of MMCA cor-
relations, both positive and negative (Madhu et al.,
unpublished observations). Many metabolite pairs that
showed positive correlations in transformed cells, such as
lactate and ala or phe and tyr, are involved in the same
biochemical pathway, which is thus the most obvious
explanation for the observed correlations. Similarly, the
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positive correlations between the TCA metabolites asp and
citrate in transformed cells may indicate a modification in
the regulation of the TCA cycle. The negative correlations
in transformed cells between Cr and PCr may be connected
with the increased Cr and PCr concentrations and the
increased PCr/Cr ratio that were measured (Supplementary
Fig. S3), all of which indicate modified energy metabolism.
The PCr/Cr ratio can be regarded as a surrogate for the
ATP/ADP ratio (since the enzyme creatine kinase catalyses
a reaction close to equilibrium) so a higher ratio suggests
that the transformed cells are in a higher energetic state.
4.1 Energy metabolism: glycolysis, glutaminolysis
and amino acid catabolism
Our initial analysis focussed on conventional metabolic
studies of substrate utilisation. Significant increases in glu-
cose consumption and lactate secretion were observed in the
E1A/RAS cells (Fig. 2a) along with over-expression of
several glucose uptake and glycolytic pathway genes (Sup-
plementary Fig. S5), suggesting the development of a more
glycolytic phenotype. Less than half of the excess glucose
consumed formed lactate, so the remainder might have gone
into biosynthesis or oxidative energy metabolism. Surpris-
ingly, the MMCA correlations between the glycolytic
metabolites glucose, ala and pyruvate observed in control
cells were lost after transformation. In Ras-transformed
mouse fibroblasts, the glycolytic enzyme PFKFB3 was an
essential downstream metabolic mediator of oncogenic RAS
(Telang et al. 2006) and up-regulation of glycolytic flux has
been reported after malignant transformation of rat liver oval
cells (Mazurek et al. 1999). In a cellular model of tumori-
genesis (Ramanathan et al. 2005) cancer-causing genes
increased glycolytic and decreased mitochondrial energy
production. Our gene expression and metabolomic data
(Supplementary Fig. S12) are consistent with these obser-
vations but present a more comprehensive description.
The control HDFs took up gln and secreted a smaller
amount of glu; both gln uptake and glu output increased
after transformation, with glu output still substantially
smaller than gln uptake. Overall, however, (Supplementary
Figs. S13, S14, S15) the main carbon source, both for
control HDFs and E1A/RAS cells, was glucose. The net
carbon contribution from uptake of gln and other amino
acids (allowing for the secretion of small amounts of ala,
glu, gly and phe) was 4–8 % of that from glucose in all
periods studied, except for days 0-3 after transformation
when it rose to 13 % (amino acid carbon net uptake as a
percentage of glucose carbon uptake: control HDFs, days
0–3, 6 %; days 3–6, 4 %; E1A/RAS transformed cells,
days 0–3, 13 %; days 3–6, 8 %; days 6–9, 8 %; days 9–12
7 %). Significantly reduced levels of all the measured
amino acids were observed in the transformed cells.
De Groof et al. recently showed that E1A/RAS trans-
formation increased oxidative phosphorylation before
causing a rise in glycolysis (de Groof et al. 2009). Since
amino acid catabolism is oxidative, the transient increase in
net amino acid carbon uptake we observed in our trans-
formed cells on days 0-3 post-transformation could have
been associated with a similar phenomenon, since amino
acids are metabolised oxidatively. The elevated glucose
uptake and lactate output by the E1A/RAS cells constituted
a Warburg effect (Warburg et al. 1924), but since oxidative
amino acid catabolism will phosphorylate approximately
15 times as much ATP per carbon atom compared with
glycolysis, and only *50 % of the glucose formed lactate
by glycolysis, the amino acids taken up were a larger
potential source of energy than the glucose.
Could the up-regulation of glycolysis and glutaminoly-
sis we observed in E1A/RAS HDFs involve a combined or
even synergic regulation of these pathways? Our MMCA
results suggest that a shift in their metabolic interaction had
indeed occurred, since the negative correlation between
glucose and glu in control cells was replaced after trans-
formation by a strongly positive one between glucose and
gln and a strongly negative one between lactate and glu; a
weaker negative correlation between lactate and gln was
conserved. These results are consistent with the correla-
tions we observed between expression of genes for gly-
colysis, the TCA cycle and amino acid metabolism
(Supplementary Fig. S11). Mazurek et al. found that weak
positive correlations between glu and lactate in control cell
lines turned to strong negative correlations during trans-
formation (Mazurek et al. 1999). DeBerardinis found that
transformed cells consumed more gln than they needed for
protein and nucleotide synthesis, thus permitting the use of
glucose-derived carbon and TCA cycle intermediates as
biosynthetic precursors (DeBerardinis et al. 2007). A recent
study showed that oncogenic K-RAS decouples glucose
and gln metabolism in order to support cancer cell growth
(Gaglio et al. 2011). Myc gene expression was also up-
regulated in our E1A/RAS cells (data not shown). Mason
et al. found up-regulation of c-Myc and subsequent acti-
vation of hTERT and other genetic events in E1A/RAS-
transformed HDFs (Mason et al. 2006), whilst Mazurek
et al. also found metabolic cooperation between different
oncogenes during cell transformation (Mazurek et al.
2001).
4.2 Amino acid metabolism
Conventional metabolic studies showed relatively little
about amino acid metabolism. Intracellular phe and tyr
were significantly decreased in transformed cells, whereas
phe and tyr consumptions were significantly increased in
the first three days after transformation (Supplementary
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Fig. S2). Additionally, secretion of two end products of the
phe catabolic pathway, fumarate and acetate, was higher in
transformed cells (Fig. 2b) and intracellular fumarate was
also significantly increased (Fig. 4b). As there is no known
mitochondrial transporter mechanism for fumarate it seems
likely that fumarate secreted into the media is formed in the
cytosol from phe and tyr catabolism.
Our MMCA results demonstrated many strong correlations
between the amino acids, particularly the branched-chain
amino acids, leu, ile and val and the aromatic amino acids phe
and tyr. There were numerous positive correlations between
ile, val, leu, lys, tyr and phe after E1A/RAS transformation but
almost none in the control HDFs. The mitochondrial branched
chain amino acid catabolism gene BCAT2 was also up-reg-
ulated whereas BCAT1, the gene for the cytosolic catabolism
enzyme was down-regulated (Supplementary Fig. S9), sug-
gesting a shift to catabolism in the mitochondrial matrix.
Figure 6 also shows that in transformed cells all branched
chain amino acids were positively correlated with each other
and that all were negatively correlated with glu, a product of
the first step in their catabolic pathway; none of those corre-
lations were observed in the control HDFs. The gene
expression correlation plots for amino acid metabolism
enzymes in supplementary Fig. S16 show several positive and
negative correlations between the catabolic pathways for
branched chain and aromatic amino acids. Expression of
pterin-4-alpha-carbinolamine dehydratase (PCBD1) in the
phenylalanine catabolic pathways is positively correlated
with that of branched chain ketoacid dehydrogenase
(BCKDHA) in the branched chain amino acid catabolic
pathway (Fig. S16). Consistent with that, the MMCA heat-
maps (Fig. 6) show strong positive correlations between phe,
tyr and the three branched chain amino acids. Thus the
branched-chain and aromatic amino acid catabolic pathways
seem to be upregulated in a concerted manner in the E1A/
RAS-transformed cells.
The strongly positive correlations between the amino acids
suggest a feed-forward interaction between the metabolites in
these pathways whereas the strongly negative correlations
between glucose and ala in control and transformed cells
suggest feed-back bias of that pathway. Supplementary Fig-
ure S11 shows pairwise gene expression correlations in gly-
colysis, the TCA cycle and amino acid metabolism. The
integrated metabolic and gene expression plots for the bran-
ched chain amino acid catabolic pathway show a number of
positive and negative correlations that might indicate feed-
forward and feed-back mechanisms respectively in these
metabolic pathways (Supplementary Figs. S9, S10).
4.3 Choline metabolites
Significant increases in Cho and phosphoethanolamine
(PE) and a significant decrease in glycerophosphocholine
(GPC) were observed after transformation; while betaine (a
Cho breakdown product) was also significantly lower
(Fig. 4a). In the membrane metabolism module, a positive
correlation observed between Cho and GPC in control
HDFs was not maintained in the transformed samples.
Instead, two new, strong negative correlations, one
between Cho and PC and another between Cho and PE,
were observed.
Elevated choline-containing metabolites have frequently
been observed by in vitro and in vivo 1H and 31P NMR in
cultured cancer cells, tumour models in animals and human
tumours (Glunde et al. 2011; Podo 1999). Phosphatidyl-
choline (PtdCho) is a major component of biological
membranes, so increased cellular PC, a metabolite
involved in its formation, might be expected in rapidly-
dividing transformed cells, and increased PC has been
proposed as a marker of malignancy (Katz-Brull et al.
2002). Upregulated remodelling of cellular membranes is
also likely in transformed cells, leading to altered con-
centrations of the PtdCho breakdown product GPC. We
found increased intracellular PC/GPC (mainly due to
decreased GPC) in the transformed cells, similar to earlier
results in transformed human mammary and prostatic
epithelial cells (Aboagye and Bhujwalla 1999; Ackerstaff
et al. 2001). The PtdCho pathway also appeared on the top
of the list of gene expression data from our Metacore
analysis of metabolic networks that are modified due to
E1A/RAS transformation (Data not shown). The Cho
transporter genes SLC22A2 and SLC44A1 (CTL1) that
were significantly overexpressed in transformed cells
(Supplementary Fig. S17) would facilitate Cho uptake.
Decreased intracellular GPC (Fig. 3a) and concomitant up-
regulation of gene expressions for four iso-enzymes of
GPC phosphodiesterase (GDPD2, GDPD3, GDPD4,
GDPD5) along with lysophospholipase (LYPLA1 and
LYPLA2) and phospholipase A2 iso-enzymes (PLA2G4A/
B/C) indicate that membrane breakdown may be more
active in transformed cells (Supplementary Fig. S17).
A puzzling group of interactions between two mem-
brane metabolites and a group of amino acids was induced
by transformation. In control HDFs Cho and PC showed no
correlations with ile, leu, phe, tyr or lys apart from a weak
positive correlation between Cho and lys. After transfor-
mation there were positive correlations between Cho and
all these amino acids whereas there were negative corre-
lations between PC and the same amino acids. Intriguingly,
this is the group of amino acids that displays uniformly
positive correlations after transformation. Another inter-
esting interaction between an amino acid and Cho is the
negative correlation between Cho and glu, seen both in the
control and transformed cells. Cho and glu participate in
neurotransmitter cycles, and glutamatergic mechanisms in
the brain have been shown to mediate cholinergic effects
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(Parikh et al. 2008). Perhaps transformed fibroblasts co-opt
cholinergic and glutamatergic signalling pathways to
enhance their growth rate. Correlations between the peaks
of glu ? gln and of choline compounds have previously
been noted in 1H MRS studies in vivo on chronic hepatitis
in human patients (Cho et al. 2001; Orlacchio et al. 2008)
and attributed by Orlacchio et al. to liver regeneration and/
or infiltration by inflammatory cells. Infiltration could not
have occurred in the present study, which was performed
on a single cell line; however the biochemistry of cellular
transformation and liver regeneration may be similar.
5 Conclusions
MMCA has demonstrated perturbed cellular metabolic
homeostasis in the transformed HDFs with generally
increased metabolite–metabolite correlations and enhanced
(or occasionally decreased) expression of related genes.
Transformation also increased glucose uptake and lactate
secretion (the Warburg effect) and amino acid catabolism,
while increased PCr/Cr, indicated an upregulated cellular
energetic state. Altered choline MMCA correlations sug-
gested increased membrane turnover. Reduced amino acid
concentrations and associated strong positive MMCA
correlations between amino-acids (as well as unexplained
MMCA interactions with choline metabolites) in trans-
formed cells may indicate remodelled amino acid meta-
bolism associated with transformation. The branched chain
amino acid catabolic pathway in mitochondria was up-
regulated in transformed HDFs, increasing secretion of
fumarate and acetate into the culture media. This combi-
nation of traditional metabolomics data (in medium and
intracellular) and gene expression, together with MMCA
which has demonstrated numerous interactions in this
system is clearly a powerful new dimension for probing the
metabolome that greatly enhances the interpretation and
understanding of the observed data.
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